Healionics Analysis: $17M Raised
What is Healionics?
Safer bloodstream access solutions for dialysis
HQ Country
Seattle, United States
Employees
1-10
Founded
2007
HQ State/Province
Washington
Funding Category
Series A
Product Features & Capabilities
- STARgraft vascular graft
- STAR® biomaterial scaffold
Other Considerations
Received FDA Breakthrough Device designation for STARgraft; Collaborates with University of Washington and Northwest Kidney Centers; Focused on improving health outcomes for kidney failure patients
HQ Full Address
2121 N 35th Street, Suite 200, Seattle, Washington 98103, United States
